Chest Pain Pilot Study

AstraZeneca

Status and phase: Completed; Phase 3

Conditions: Gastroesophageal Reflux; Chest Pain

Treatments: Drug: Esomeprazole

Study type: Interventional

Funder types: Industry

Identifiers

NCT00251901

D9914C00001

Details and patient eligibility

About

The purpose of this study is to compare the efficacy of Nexium® with placebo in relief of acid related pain or discomfort in the chest.

Sex: All

Ages: 18 to 70 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Pain or discomfort in the chest without any identifiable cause and severe enough for the patient to seek primary medical or similar care.
• History of pain or discomfort in the chest for at least the last two weeks prior to enrollment.

Exclusion criteria

• Signs, symptoms or relevant investigations suggestion present symptomatic coronary heart disease.
• Patients whose pain or discomfort in the chest warrants urgent cardiac investigation.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind